Mycenax Biotech (4726) — Free Cash Flow Generation Index

Latest as of March 2025: -4.90x

Mycenax Biotech (4726) has a Free Cash Flow Generation Index of -4.90x as of March 2025. Free cash flow of NT$-70.01 Million represents -5% of operating cash flow (NT$14.29 Million). Explore Mycenax Biotech capital reinvestment ratio to see what proportion of operating cash flow is directed to capital expenditures.

FCF Generation Index

-4.90x

Free Cash Flow / Operating CF

Free Cash Flow

NT$-70.01 Million

TWD

Operating Cash Flow

NT$14.29 Million

TWD

Capital Expenditures

NT$84.30 Million

TWD

Mycenax Biotech Free Cash Flow Generation Index (2020–2020)

Historical FCF Generation Index trend for Mycenax Biotech across 1 annual periods. For the full cash flow conversion analysis, see 4726 cash flow metrics.

Annual Free Cash Flow Generation for Mycenax Biotech (2020–2020)

Year-by-year Free Cash Flow Generation Index for Mycenax Biotech. Check cash flow reinvestment rate of Mycenax Biotech to assess the company's total reinvestment commitment from operating cash flow.

Year	FCG Index	Free Cash Flow (TWD)	Operating CF	Capital Expenditures	YoY Change
2020	-0.51x	NT$-88.09 Million	NT$174.17 Million	NT$260.22 Million	—

FCG Index = Free Cash Flow / Operating Cash Flow. FCF = Operating CF + Capital Expenditures (capex stored negative).